Jesse Jung, MD
Ophthalmology · Oakland, CANPI 1033351689
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 53.3% of the total. Reporting peaked in 2019 at $31,892 and has fallen 86.1% since, to $4,441 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $485.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$36K
- Chugai Pharmaceutical Co., Ltd.$13K
- AbbVie$8K
- Regeneron$4K
- Topcon Healthcare, Inc.$3K
- Genentech, Inc.$2K
- plus $3K from 14 others
Across 6 payments — averaging $2247.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Carl Zeiss Meditec, Inc.$9K
- F. Hoffmann-la Roche AG$5K
What the payments were for
- Consulting fees$28,30141%
- Speaking & faculty fees$22,41033%
- Travel & lodging$11,08916%
- Food & beverage$4,0676%
- Education$2,5004%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 37 | $36,459 |
| Chugai Pharmaceutical Co., Ltd. | 4 | $12,732 |
| AbbVie | 17 | $7,663 |
| Regeneron | 13 | $3,720 |
| Topcon Healthcare, Inc. | 1 | $2,500 |
| Genentech, Inc. | 7 | $2,067 |
| Alimera Sciences, Inc. | 8 | $1,476 |
| Genentech USA, Inc. | 28 | $958 |
| Astellas Pharma US Inc | 15 | $405 |
| Heidelberg Engineering, Inc. | 1 | $88 |
| Alcon | 1 | $61 |
| Astellas Pharma Global Development | 1 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Amgen | 1 | $27 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $19 |
| Eyepoint US, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$19,605
- FORUM$10,000
- VisuMax$9,375
- OPMI Lumera 700$7,380
- OZURDEX$7,289
- Clarus 700$4,950
- Cataract Suite$3,530
- EYLEA HD$3,290
- CIRRUS 6000 with AngioPlex$2,975
- Humphrey Field Analyzer (HFA3)$2,975
- OCT MAESTRO$2,500
- PLEX Elite$2,434
- CLARUS$2,165
- Lucentis$1,760
- QUATERA 700$1,540
- CALLISTO eye$1,540
- Iluvien$1,248
- IOLMaster 700$1,136
- FORUM Glaucoma Workplace$665
- Retina Workplace$665
How this compares
$68,386 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 71 | $3,851 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 55 | $886 |
| Ketorolac Tromethamine | 43 | $734 |
| Latanoprost | 43 | $703 |
| Brimonidine Tartrate | 16 | $425 |
| Atropine Sulfate | 11 | $334 |
| Dorzolamide Hcl | 18 | $222 |
| Timolol Maleate | 13 | $167 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Oakland
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.